Palliative care in liver disease: what does good look like?
- PMID: 32419913
- PMCID: PMC7223359
- DOI: 10.1136/flgastro-2019-101180
Palliative care in liver disease: what does good look like?
Abstract
The mortality rate from chronic liver disease in the UK is rising rapidly, and patients with advanced disease have a symptom burden comparable to or higher than that experienced in other life-limiting illnesses. While evidence is limited, there is growing recognition that care of patients with advanced disease needs to improve. Many factors limit widespread provision of good palliative care to these patients, including the unpredictable trajectory of chronic liver disease, the misconception that palliative care and end-of-life care are synonymous, lack of confidence in prescribing and lack of time and resources. Healthcare professionals managing these patients need to develop the skills to ensure effective delivery of core palliative care, with referral to specialist palliative care services reserved for those with complex needs. Core palliative care is best delivered by the hepatology team in parallel with active disease management. This includes ensuring that discussions about disease trajectory and advance care planning occur alongside active management of disease complications. Liver disease is strongly associated with significant social, psychological and financial hardships for patients and their carers; strategies that involve the wider multidisciplinary team at an early stage in the disease trajectory help ensure proactive management of such issues. This review summarises the evidence supporting palliative care for patients with advanced chronic liver disease, presents examples of current best practice and provides pragmatic suggestions for how palliative and disease-modifying care can be run in parallel, such that patients do not miss opportunities for interventions that improve their quality of life.
Keywords: cirrhosis; end of life.
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
[Palliative care in the cardiac setting: a consensus document of the Italian Society of Cardiology/Italian Society of Palliative Care (SIC/SICP)].G Ital Cardiol (Rome). 2019 Jan;20(1):46-61. doi: 10.1714/3079.30720. G Ital Cardiol (Rome). 2019. PMID: 30638215 Italian.
-
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809. JBI Database System Rev Implement Rep. 2015. PMID: 26447011
-
The incompatibility of healthcare services and end-of-life needs in advanced liver disease: A qualitative interview study of patients and bereaved carers.Palliat Med. 2018 May;32(5):908-918. doi: 10.1177/0269216318756222. Epub 2018 Feb 2. Palliat Med. 2018. PMID: 29393806
-
Palliative care and end-stage liver disease: a critical review of current knowledge.Curr Opin Gastroenterol. 2019 May;35(3):155-160. doi: 10.1097/MOG.0000000000000530. Curr Opin Gastroenterol. 2019. PMID: 30925536 Review.
-
Supportive and palliative care needs in advanced non-malignant liver disease: systematic review.BMJ Support Palliat Care. 2024 Dec 19;14(e3):e2341-e2348. doi: 10.1136/spcare-2024-004785. BMJ Support Palliat Care. 2024. PMID: 38724224
Cited by
-
Two mental models of integrated care for advanced liver disease: qualitative study of multidisciplinary health professionals.BMJ Open. 2022 Sep 5;12(9):e062836. doi: 10.1136/bmjopen-2022-062836. BMJ Open. 2022. PMID: 36691142 Free PMC article.
-
AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis.Hepatology. 2022 Sep;76(3):819-853. doi: 10.1002/hep.32378. Epub 2022 Apr 22. Hepatology. 2022. PMID: 35103995 Free PMC article. No abstract available.
-
Non-Selective Beta-Blockers Decrease Infection, Acute Kidney Injury Episodes, and Ameliorate Sarcopenic Changes in Patients with Cirrhosis: A Propensity-Score Matching Tertiary-Center Cohort Study.J Clin Med. 2021 May 21;10(11):2244. doi: 10.3390/jcm10112244. J Clin Med. 2021. PMID: 34064207 Free PMC article.
-
Hepatic Hydrothorax: A Narrative Review.Pulm Ther. 2022 Sep;8(3):241-254. doi: 10.1007/s41030-022-00195-8. Epub 2022 Jun 25. Pulm Ther. 2022. PMID: 35751800 Free PMC article. Review.
-
Palliative care in terminally ill advanced chronic liver disease patients.Wien Klin Wochenschr. 2025 Jun;137(11-12):342-350. doi: 10.1007/s00508-024-02436-z. Epub 2024 Sep 10. Wien Klin Wochenschr. 2025. PMID: 39254776 Free PMC article. Review.
References
-
- Williams R, Aspinall R, Bellis M, et al. . Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet 2014;384:1953–97. 10.1016/S0140-6736(14)61838-9 - DOI - PubMed
-
- National End of Life Intelligence Network Deaths from liver disease: implications for end of life care in England, 2012. Available: http://www.endoflifecare-intelligence.org.uk/resources/publications/deat...
-
- Public Health England Statistical commentary: end of life care profiles, 2018. Available: https://www.gov.uk/government/publications/end-of-life-care-profiles-feb...
Publication types
LinkOut - more resources
Full Text Sources